Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3

NCT04649229 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: LCZ 696
DRUG: Placebo
DRUG: Para-aminohippurate
DRUG: Iohexol
DRUG: Aprepitant

Sponsor

Yale University